Delayed
London S.E.
09:05:03 22/05/2024 pm IST
|
5-day change
|
1st Jan Change
|
1.675
GBX
|
0.00%
|
|
0.00%
|
-14.10%
|
Fiscal Period: December |
2021
|
2022
|
2023
|
---|
Capitalization
1 |
7.603
|
5.034
|
7.095
|
Enterprise Value (EV)
1 |
6.728
|
4.556
|
5.538
|
P/E ratio
|
-1.23
x
|
-4.63
x
|
-4.04
x
|
Yield
|
-
|
-
|
-
|
Capitalization / Revenue
|
-
|
-
|
-
|
EV / Revenue
|
-
|
-
|
-
|
EV / EBITDA
|
-
|
-
|
-
|
EV / FCF
|
25,81,653
x
|
-67,60,956
x
|
-3,23,85,462
x
|
FCF Yield
|
0%
|
-0%
|
-0%
|
Price to Book
|
8.11
x
|
1.87
x
|
4.71
x
|
Nbr of stocks (in thousands)
|
2,53,448
|
3,47,175
|
3,63,842
|
Reference price
2 |
0.0300
|
0.0145
|
0.0195
|
Announcement Date
|
21/06/22
|
27/04/23
|
30/04/24
|
Fiscal Period: December |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Net sales
1 |
0.025
|
-
|
-
|
-
|
-
|
-
|
EBITDA
1 |
-0.0264
|
-0.0203
|
-
|
-
|
-
|
-
|
EBIT
1 |
-0.0279
|
-0.0217
|
-0.014
|
-0.798
|
-0.963
|
-0.976
|
Operating Margin
|
-111.57%
|
-
|
-
|
-
|
-
|
-
|
Earnings before Tax (EBT)
1 |
-0.0279
|
-0.0217
|
-0.014
|
-3.958
|
-0.963
|
-1.763
|
Net income
1 |
-0.0279
|
-0.0217
|
-0.014
|
-3.921
|
-0.912
|
-1.717
|
Net margin
|
-111.54%
|
-
|
-
|
-
|
-
|
-
|
EPS
2 |
-0.0888
|
-0.0691
|
-0.0283
|
-0.0244
|
-0.003130
|
-0.004824
|
Free Cash Flow
|
-
|
0.001067
|
-0.009936
|
2.606
|
-0.6739
|
-0.171
|
FCF margin
|
-
|
-
|
-
|
-
|
-
|
-
|
FCF Conversion (EBITDA)
|
-
|
-
|
-
|
-
|
-
|
-
|
FCF Conversion (Net income)
|
-
|
-
|
-
|
-
|
-
|
-
|
Dividend per Share
|
-
|
-
|
-
|
-
|
-
|
-
|
Announcement Date
|
21/05/19
|
23/04/21
|
21/06/22
|
21/06/22
|
27/04/23
|
30/04/24
|
Fiscal Period: December |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Net Debt
1 |
-
|
-
|
0
|
-
|
-
|
-
|
Net Cash position
1 |
0.02
|
0.01
|
-
|
0.88
|
0.48
|
1.56
|
Leverage (Debt/EBITDA)
|
-
|
-
|
-
|
-
|
-
|
-
|
Free Cash Flow
|
-
|
0
|
-0.01
|
2.61
|
-0.67
|
-0.17
|
ROE (net income / shareholders' equity)
|
-161%
|
-124%
|
2,047%
|
-844%
|
-51%
|
-82.8%
|
ROA (Net income/ Total Assets)
|
-51.9%
|
-41.4%
|
-66.1%
|
-85.6%
|
-30.6%
|
-27.2%
|
Assets
1 |
0.0537
|
0.0524
|
0.0212
|
4.579
|
2.985
|
6.302
|
Book Value Per Share
2 |
0.0100
|
0.0200
|
-0.0200
|
0
|
0.0100
|
0
|
Cash Flow per Share
2 |
0.0600
|
0.0400
|
0.0100
|
0
|
0
|
0
|
Capex
|
-
|
-
|
-
|
-
|
-
|
-
|
Capex / Sales
|
-
|
-
|
-
|
-
|
-
|
-
|
Announcement Date
|
21/05/19
|
23/04/21
|
21/06/22
|
21/06/22
|
27/04/23
|
30/04/24
|
|
1st Jan change
|
Capi.
|
---|
| -14.10% | 84.5L | | +64.23% | 6.26TCr | | -2.31% | 4.12TCr | | +44.36% | 4.03TCr | | -8.29% | 2.79TCr | | +11.97% | 2.62TCr | | -21.16% | 1.91TCr | | +7.54% | 1.31TCr | | +27.17% | 1.21TCr | | +25.72% | 1.23TCr |
Other Biotechnology & Medical Research
|